These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Copper-7 intrauterine device (Gravigard). Report of experience]. Jürgensen O; Stenzel I; Wirth A; Sina D; Taubert HD Fortschr Med; 1976 Mar; 94(9):515-21. PubMed ID: 964914 [TBL] [Abstract][Full Text] [Related]
3. Intrauterine devices: an effective alternative to oral hormonal contraception. Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436 [TBL] [Abstract][Full Text] [Related]
4. Experience with the Copper-7 and Copper-T intrauterine devices at Siriraj Hospital in Bangkok, Thailand. Koetsawang S; Srisupandit S; Bhiraleus P; Rachawat D; Kiriwat O; Jirochkul V; Mitra M; Thomas M J Med Assoc Thai; 1982 Jan; 65(1):12-7. PubMed ID: 6153035 [TBL] [Abstract][Full Text] [Related]
5. A three-year study of the copper-7 minigravigard intrauterine contraceptive device in nulliparous women. Srisupandit S J Med Assoc Thai; 1988 Jun; 71(6):294-7. PubMed ID: 3171448 [TBL] [Abstract][Full Text] [Related]
7. Do copper containing intrauterine contraceptive devices need to be changed after 2 years? Dunn K; Kovacs GT Clin Reprod Fertil; 1983 Dec; 2(4):283-7. PubMed ID: 6678604 [TBL] [Abstract][Full Text] [Related]
8. [Comparison of intra-uterine devices, Copper-T-200 and Dana-Super-Fix-Cuprum (author's transl)]. Melzer H; Heyer E; Hielscher K; Schneider W Zentralbl Gynakol; 1980; 102(22):1283-7. PubMed ID: 7223144 [TBL] [Abstract][Full Text] [Related]
9. [The clinical efficacy of the copper-containing intrauterine devices Nova T and Copper-T-200 Ag in a randomized study (author's transl)]. Altmann G; Feichtinger W; Havelec L; Beck A Wien Klin Wochenschr; 1981 Sep; 93(17):556-8. PubMed ID: 7303702 [TBL] [Abstract][Full Text] [Related]
10. The Nova-T 200 intrauterine contraceptive device: a 12 year study. Baeyertz JD; Hartfield VJ N Z Med J; 1997 May; 110(1043):169-71. PubMed ID: 9196502 [TBL] [Abstract][Full Text] [Related]
11. Performances of copper T 380A and multiload copper 375/250 intrauterine contraceptive devices in a comparative clinical trial. Arowojolu AO; Otolorin EO; Ladipo OA Afr J Med Med Sci; 1995 Mar; 24(1):59-65. PubMed ID: 7495202 [TBL] [Abstract][Full Text] [Related]
12. Problems in the conduct and analysis of "A comparative randomized study of three different IUDs in nulliparous Mexican women". Sivin I Contraception; 2004 Mar; 69(3):259-60. PubMed ID: 14969676 [No Abstract] [Full Text] [Related]
13. Complications among adolescents using copper intrauterine contraceptive devices. Rasheed SM; Abdelmonem AM Int J Gynaecol Obstet; 2011 Dec; 115(3):269-72. PubMed ID: 21872240 [TBL] [Abstract][Full Text] [Related]
18. [Intrauterine contraceptive devices. Mode of action, experiences, complications (author's transl)]. Ludwig H Geburtshilfe Frauenheilkd; 1976 Feb; 36(2):97-108. PubMed ID: 943359 [TBL] [Abstract][Full Text] [Related]
19. Factors affecting the clinical performance of Nova T and Copper T 200. Allonen H; Luukkainen T; Nielsen NC; Nygren KG; Pyörälä T Obstet Gynecol; 1984 Oct; 64(4):524-9. PubMed ID: 6384847 [TBL] [Abstract][Full Text] [Related]
20. [Clinical experiences with the Medusa Cu 240 Ag intrauterine device]. Girardi F Wien Klin Wochenschr; 1993; 105(24):728-31. PubMed ID: 8116311 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]